OpenAI Invests in Merge Labs, Sam Altman's Brain-Computer Interface Startup

OpenAI invests in Merge Labs, the brain-computer interface startup founded by Sam Altman, in a 250 million dollar funding round.

OpenAI Invests in Merge Labs, Sam Altman's Brain-Computer Interface Startup
Merge Labs logo with brain-computer interface elements

On January 15, 2026, OpenAI announced a significant investment in the startup Merge Labs, founded by OpenAI CEO Sam Altman. This investment marks an important step in the evolution of brain-computer interfaces (BCIs) and in the collaboration between artificial intelligence and neuroscience.

A strategic investment in the future of BCIs

Merge Labs, which recently emerged from stealth, has completed a 250 million dollar seed funding round, valuing the company at 850 million dollars. OpenAI participated as the lead investor, recognizing the potential of BCIs as a new technological frontier. BCIs offer innovative ways to communicate, learn and interact with technology, promising a more natural, human-centered interaction with AI.

Merge Labs' mission

Merge Labs aims to bridge the gap between biological and artificial intelligence by developing non-invasive technologies that connect the human brain to AI. Unlike earlier approaches, such as Neuralink's, which require invasive surgery, Merge Labs aims to use molecules and technologies such as ultrasound to interact with neurons, reducing the risks associated with brain implants.

Implications for the tech and healthcare sectors

OpenAI's investment in Merge Labs not only strengthens Altman's position in the BCI field, but also signals growing interest in non-invasive applications in neuroscience and AI. Potential applications range from the rehabilitation of people with motor disabilities to the creation of more intuitive interfaces between humans and machines, opening new opportunities for technological innovation and improving quality of life.

Conclusion

  • Innovation in BCIs: Merge Labs is developing non-invasive technologies to connect the human brain to AI, a significant advance in the field of brain-computer interfaces.
  • Strategic collaboration: OpenAI's investment underlines the importance of collaboration between leading AI companies and emerging startups to accelerate innovation.
  • Future implications: The technologies developed by Merge Labs could revolutionize the way we interact with technology, offering new solutions to medical challenges and improving human-machine interaction.